Search Results

15 results

  1. Bull. ARN, 2003, p. 27-39., ISSN.1146-6200

    Tobacco as a model plant to study the infectious structures of pathogen bacteria

    RACAPE J.; PARLANGE F.; BELBAHRI L.; NICOLE M.; VERRIER J.L.; DELON R.; KELLER H.
    INRA, Unité Interactions Plantes-Microorganismes et Santé Végétale, Antibes, France
    Bacterial pathogens use common strategies to infect their host cells in plants or animals. Among these strategies, the type III secretion system allows not only the secretion, but also the injection of pathogenicity factors into eucaryotic host cells. To ...
  2. Bull. ARN, 2003, p. 69-77., ISSN.1146-6200

    Effects of selenium supplementation on the in vitro and in vivo immuntoxic properties of tobacco tars

    NGUYEN VAN BINH P.; DONG Z.; BAUDOUIN F.; MARTIN C; RADIONOF M.; THEVENIN M.; WARNET J-M; HUYNH THIEN DUC G.
    Université Rene Descartes - Paris5, Laboratoire de Toxicologie, Faculte des Sciences Pharmaceutiques et Biologiques, Paris, France
    Preparations of tobacco tar differently supplemented with selenium (Se) have been studied for their immunotoxic and immunomodulatory effects. In particular, studies have been performed on the in vitro expression of the major histocompatibility complex ...
  3. Bull. ARN, 2004, p. 23-41., ISSN.1146-6200.

    Role of the interaction between diesel particulate matter and cigarette smoke in the pathophysiology of chronic obstructive pulmonary disease (COPD)

    LANONE S.; AMATA N.; BACHOUAL R.; AUBIER M.; BOCZKOWSKI J.
    INSERM U408, Faculté Xavier Bichat, Paris, France
    Chronic obstructive pulmonary disease (COPD) is a disease state characterized by airflow limitation that is not fully reversible, leading to respiratory insufficiency. Flow limitation is secondary to the remodeling of the pulmonary parenchyma (called also ...
  4. Bull. ARN, 2004, p. 3-10., ISSN.1146-6200.

    The Phytinove project : production in tobacco plants and purification of proteins of pharmaceutical interest

    MALEMBIC-MAHER S.; FAIDERBE-COMEAU S.; BATAILLE L.; MOYNET D.; BEZIAN J-H.
    Phytinove, Bordeaux, France
    Phytinove is a new biotech company that specialises in engineering, production in bacteria and plants, and purification of recombinant pharmaceutical proteins. Collaborating with the Molecular Immunology Laboratory of Bordeaux 2 University, Phytinove ...